FI905195A0 - Laongvarigt frigoerande element. - Google Patents

Laongvarigt frigoerande element.

Info

Publication number
FI905195A0
FI905195A0 FI905195A FI905195A FI905195A0 FI 905195 A0 FI905195 A0 FI 905195A0 FI 905195 A FI905195 A FI 905195A FI 905195 A FI905195 A FI 905195A FI 905195 A0 FI905195 A0 FI 905195A0
Authority
FI
Finland
Prior art keywords
front loading
loading element
loading
Prior art date
Application number
FI905195A
Other languages
English (en)
Finnish (fi)
Inventor
Louis Michel Jacques Aguadisch
Alain Etienne
Bernard Francis Grisoni
Original Assignee
Dow Corning Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Corning Sa filed Critical Dow Corning Sa
Publication of FI905195A0 publication Critical patent/FI905195A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
    • A61K9/2036—Silicones; Polysiloxanes

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI905195A 1989-10-23 1990-10-22 Laongvarigt frigoerande element. FI905195A0 (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8913818A FR2653337B1 (fr) 1989-10-23 1989-10-23 Element a liberation prolongee et procede pour le fabriquer.

Publications (1)

Publication Number Publication Date
FI905195A0 true FI905195A0 (fi) 1990-10-22

Family

ID=9386646

Family Applications (1)

Application Number Title Priority Date Filing Date
FI905195A FI905195A0 (fi) 1989-10-23 1990-10-22 Laongvarigt frigoerande element.

Country Status (13)

Country Link
EP (1) EP0425154B1 (fr)
JP (1) JPH03167116A (fr)
KR (1) KR910007518A (fr)
AU (1) AU639947B2 (fr)
BR (1) BR9005223A (fr)
CA (1) CA2027865A1 (fr)
DE (1) DE69003347T2 (fr)
DK (1) DK0425154T3 (fr)
ES (1) ES2044451T3 (fr)
FI (1) FI905195A0 (fr)
FR (1) FR2653337B1 (fr)
HU (1) HUT69395A (fr)
IE (1) IE66826B1 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721365A (en) * 1989-09-15 1998-02-24 Us Health N-substituted piperazine NONOates
US5208233A (en) * 1989-09-15 1993-05-04 The United States Of America As Represented By The Department Of Health And Human Services Anti-hypertensive compositions of secondary amine-nitric oxide adducts and use thereof
FR2677253A1 (fr) * 1991-06-07 1992-12-11 Union Metropolitaine Pharmaceu Composition therapeutique utile vis-a-vis des maladies inflammatoires du systeme gastro-intestinal.
CA2119572C (fr) * 1991-09-24 2005-07-05 Larry Kay Keefer Derives d'additifs oxyde nitrique-nucleophile a substitut oxygene utilises comme precurseurs de medicaments donneurs de groupements oxyde nitrique
US5691423A (en) * 1992-08-24 1997-11-25 The United States Of America As Represented By The Department Of Health And Human Services Polysaccharide-bound nitric oxide-nucleophile adducts
US5405919A (en) * 1992-08-24 1995-04-11 The United States Of America As Represented By The Secretary Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions and methods of treating biological disorders
US6200558B1 (en) 1993-09-14 2001-03-13 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5525357A (en) * 1992-08-24 1996-06-11 The United States Of America As Represented By The Department Of Health And Human Services Polymer-bound nitric oxide/nucleophile adduct compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5910316A (en) * 1992-08-24 1999-06-08 The United States Of America, As Represented By The Department Of Health And Human Services Use of nitric oxide-releasing agents to treat impotency
US5714511A (en) * 1995-07-31 1998-02-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Selective prevention of organ injury in sepsis and shock using selection release of nitric oxide in vulnerable organs
FR2752380B1 (fr) * 1996-08-14 1998-10-30 Dow Corning Sa Procede de fabrication d'un dispositif a liberation controlee
US6261594B1 (en) 1998-11-25 2001-07-17 The University Of Akron Chitosan-based nitric oxide donor compositions
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
TR200300731T2 (tr) 2000-11-28 2004-08-23 Fmc Corporation Yenebilir PGA kaplama bileşimi
KR100477364B1 (ko) * 2002-07-03 2005-03-22 주식회사 메디켐스 신규한 헬리코박터 파이로리 균 진단용 13ｃ-요소 캅셀 제제
MY142204A (en) 2002-07-25 2010-10-29 Pharmacia Corp Pramipexole once-daily dosage form
PL1789021T3 (pl) 2004-08-13 2012-04-30 Boehringer Ingelheim Int Preparat tabletkowy o przedłużonym uwalnianiu zawierający pramipeksol lub jego farmaceutycznie dopuszczalną sól
CA2576386A1 (fr) 2004-08-13 2006-02-16 Boehringer Ingelheim International Gmbh Preparation d'une pastille a autorisation de sortie elargie, contenant du pramipexole ou un sel de pramipexole pharmaceutiquement acceptable, procede de fabrication et d'utilisation de cette pastille
ATE396710T1 (de) * 2005-07-19 2008-06-15 Ethypharm Sa Gastroretentive zusammensetzungen und verfahren zur herstellung
WO2007086078A2 (fr) * 2006-01-30 2007-08-02 Panacea Biotec Ltd. Compositions pharmaceutiques atypiques et processus de preparation correspondant
GB0909680D0 (en) 2009-06-05 2009-07-22 Euro Celtique Sa Dosage form
JP5690398B2 (ja) * 2010-04-14 2015-03-25 メンリッケ・ヘルス・ケア・アーベー 抗菌性ゲル
KR101858797B1 (ko) 2010-05-10 2018-05-16 유로-셀티큐 에스.에이. 히드로모르폰 및 날록손을 포함하는 제약 조성물
KR20130030261A (ko) 2010-05-10 2013-03-26 유로-셀티큐 에스.에이. 활성제-무함유 과립 및 그를 포함하는 정제의 제조
MX344846B (es) 2010-05-10 2017-01-10 Euro-Celtique S A * Combinacion de granulos cargados activos con activos adicionales.
GB201020895D0 (en) 2010-12-09 2011-01-26 Euro Celtique Sa Dosage form
EA030310B1 (ru) 2013-11-13 2018-07-31 Эро-Селтик С.А. Гидроморфон и налоксон для лечения боли и индуцированного опиоидами синдрома дисфункции кишечника
KR101599126B1 (ko) 2014-04-01 2016-03-14 주식회사 명성 스크루식 뚜껑 성형장치
SI4037666T1 (sl) 2020-12-08 2024-09-30 Ruminant Biotech Corp Limited Izboljšave naprav in postopkov za dostavo snovi živalim
WO2023148316A1 (fr) * 2022-02-03 2023-08-10 Basf Se Diacétate de magnésium x 4h 2o et/ou dichlorure de magnésium x 6h 2o et/ou sulfate de magnésium x 2o et/ou sulfate disodique x 10 h 2o et/ou thiosulfate de sodium x 5h 2o et/ou na 3po 4 x 12 h 2o et/ou na 2hpo 4 x 12h 2o/7h 2o et/ou acétate de sodium x 3h 2o en tant qu'auxiliaire de granulation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE791632A (fr) * 1971-11-20 1973-05-21 Schering Ag Supports a base de caoutchouc siliconique pour agents medicamenteux
US3991750A (en) * 1975-04-28 1976-11-16 Syntex Corporation Dromostanolone propionate implant pellet useful for producing weight gains in animals and suppressing estrus in female animals
SE8203953D0 (sv) * 1982-06-24 1982-06-24 Astra Laekemedel Ab Pharmaceutical mixture
CA1331338C (fr) * 1987-02-03 1994-08-09 Dow Corning Corporation Compositions aqueuses formant une pellicule, utilisees pour reguler la liberation d'agents actifs, et procede pour leur fabrication
FR2610827B1 (fr) * 1987-02-18 1991-09-13 Pf Medicament Comprime de dihydroergotamine (d.h.e.) du type a matrice hydrophile et son procede de fabrication
GB8704755D0 (en) * 1987-02-28 1987-04-01 Dow Corning Ltd Pharmaceutical delivery device

Also Published As

Publication number Publication date
FR2653337A1 (fr) 1991-04-26
BR9005223A (pt) 1991-09-17
FR2653337B1 (fr) 1992-02-07
DK0425154T3 (da) 1993-11-01
DE69003347D1 (de) 1993-10-21
AU639947B2 (en) 1993-08-12
JPH03167116A (ja) 1991-07-19
DE69003347T2 (de) 1994-02-17
HUT69395A (en) 1995-09-28
AU6486390A (en) 1991-04-26
EP0425154B1 (fr) 1993-09-15
ES2044451T3 (es) 1994-01-01
EP0425154A1 (fr) 1991-05-02
IE66826B1 (en) 1996-02-07
KR910007518A (ko) 1991-05-30
IE903777A1 (en) 1991-04-24
HU906525D0 (en) 1991-04-29
CA2027865A1 (fr) 1991-04-24

Similar Documents

Publication Publication Date Title
FI905195A0 (fi) Laongvarigt frigoerande element.
DE59000343D1 (de) Schaelmesser.
DE69017059D1 (de) Mehrplattenspieler.
DE59007379D1 (de) 3-Phenylbenzofuran-2-one.
FI912578A0 (fi) Funktionsenhet.
DE69006276D1 (de) Fördermittel.
FI913848A0 (fi) Tillsatsanordning till fordon.
DE59004522D1 (de) Mikrodosiergerät.
DE69020950D1 (de) Mehrplattenspieler.
DE59005135D1 (de) Formstein.
DE59008431D1 (de) Triazolylsulfonamide.
NO900540L (no) Fiskedamkonstruksjon.
DE59009874D1 (de) Iminosilane.
DE69004689D1 (de) N-fluoropyridinium-pyridin-heptafluorodiborat.
DE69013427D1 (de) Glyoxyl-Cyclohexendione.
DE59008846D1 (de) Fluorphenylpyrimidine.
DE59007719D1 (de) Pyrazol-3-carbonsäureamide.
FI890191A0 (fi) Frekvensmodulerad saendarmottagare.
DE69008037D1 (de) Satteldecke.
FI890327A0 (fi) Sidobalkfaeste foer bilkorgsutraetningsanordning.
DE69001981D1 (de) Kaefigmutter.
NO882898L (no) Frontlaster.
FI894054A0 (fi) Hjaelpanordning till en ansiktsmask.
FI914697A0 (fi) Foerbaettringar till ammunitionsenheter.
FI905889A (fi) Basiska polysackarider.

Legal Events

Date Code Title Description
FD Application lapsed
FD Application lapsed

Owner name: DOW CORNING FRANCE S.A.